سعر باينواي 3% 2024

Felbinac 3% topical gel 50 g (Marcyrl / Geopharma, Egypt), a topical NSAID for musculoskeletal pain and inflammation.

• Painful inflammatory musculoskeletal conditions: soft-tissue trauma (sprains, strains, contusions)Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
• Extra-articular rheumatic conditions (bursitis, capsulitis, frozen shoulder, myalgia, tendonitis, tenosynovitis, tennis elbow)Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland
• Pain and stiffness of non-serious arthritic conditionsPopulation: AdultsHealth Products Regulatory Authority (HPRA), Ireland

• Local erythema, irritation, dermatitis, pruritus and paraesthesia; rarely bronchospasm, GI disturbance, widespread rash; anaphylaxis and bullous dermatoses (frequency not known).International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Hypersensitivity to felbinac or excipients; asthma, urticaria or rhinitis triggered by aspirin or other NSAIDs.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Broken or denuded skin, local infection, occlusive dressings, or other topical products on the same site.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Active peptic ulceration; pregnancy and breast-feeding.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Use with caution in renal, cardiac or hepatic impairment, history of peptic ulcer, inflammatory bowel disease or bleeding diathesis; avoid eyes/mucosa and excessive sun exposure of treated areas.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

• Other medicines (general)Highly protein bound but serum levels after topical use are extremely low, so clinical interactions are unlikely.Health Products Regulatory Authority (HPRA), Ireland

• Contraindicated in pregnancy: felbinac is suspected to cause serious birth defects; dystocia and delayed parturition seen in animals.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
• Contraindicated during breast-feeding.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

English text not available for this section.